FUSEN PHARM (01652): Metformin and Linagliptin Tablets (I) Tentatively Win the Bid for the 11th Batch of National Drug Centralized Procurement Bidding in China.
Fosun Pharma (01652) issued an announcement on the 11th batch of national centralized procurement of drugs in China on October 27, 2025.
FUSEN PHARM (01652) announced that in the results of the 11th batch of National Drug Centralized Procurement Tender in China on October 27, 2025, one product of the group is intended to be selected: Metformin Glimepiride Tablets (I) ( Metformin Hydrochloride 500mg and Glimepiride 5mg ).
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
